UCB Pharma S.A.

Braine-l'Alleud, BelgiumFEI 3003909356API manufacture registered

UCB Pharma S.A. is a drug establishment in Braine-l'Alleud, Belgium, registered with the US FDA under FEI 3003909356. Its registered operations are: Analytical testing, API manufacture, Labelling, Drug manufacture, Packaging, Relabelling, Repackaging. 12 EU/UK GMP certificates are matched to this site, 5 inspected within the last three years.

Sources: FDA Drug Establishments Current Registration Site (checked 2 Nov 2026); EudraGMDP; MHRA GMDP. Methodology

Registered operations

Business operations this establishment declares in its FDA registration. Registration is not an approval and says nothing about EU or UK GMP status.

Analytical testingAPI manufactureLabellingDrug manufacturePackagingRelabellingRepackaging

GMP documents matched to this site (12)

DocumentAuthorityInspectionSource
BE/GMP/2025/072
GMP certificate
Competent authority of Belgium12 Jun 2025
within 3-year review window
EudraGMDP
BE/GMP/2025/071
GMP certificate
Competent authority of Belgium12 Jun 2025
within 3-year review window
EudraGMDP
BE/GMP/2025/024
GMP certificate
Competent authority of Belgium21 Feb 2025
within 3-year review window
EudraGMDP
BE/GMP/2024/004
GMP certificate
Competent authority of Belgium1 Feb 2024
within 3-year review window
EudraGMDP
BE/GMP/2024/005
GMP certificate
Competent authority of Belgium1 Feb 2024
within 3-year review window
EudraGMDP
BE/GMP/2023/073
GMP certificate
Competent authority of BELGIUM7 Jul 2023
outside 3-year review window
EudraGMDP
BE/GMP/2023/072
GMP certificate
Competent authority of BELGIUM7 Jul 2023
outside 3-year review window
EudraGMDP
BE/GMP/2023/048
GMP certificate
Competent authority of Belgium5 Jun 2023
outside 3-year review window
EudraGMDP
BE/GMP/2023/053
GMP certificate
Competent authority of Belgium11 May 2023
outside 3-year review window
EudraGMDP
BE/GMP/2023/052
GMP certificate
Competent authority of Belgium11 May 2023
outside 3-year review window
EudraGMDP
BE/GMP/2021/139
GMP certificate
Competent authority of Belgium25 Nov 2021
outside 3-year review window
EudraGMDP
BE/GMP/2021/140
GMP certificate
Competent authority of Belgium25 Nov 2021
outside 3-year review window
EudraGMDP

A GMP document is matched to this site when its address names the site's street and its city or postcode. In our latest internal review 59 of 60 sampled matches were the right site (not yet independently reviewed; measured match quality). Check the certificate's own address before relying on it. The three-year review window is the EMA guideline default after an inspection, not an official expiry date.

What this page does not show

  • Which substances are made here: DMFs and CEPs are filed by organisations, not sites, so we do not link substances to this site.
  • Capacity, scale, price or current availability: no regulator publishes these.
  • FDA inspection classifications for this site, which are not yet linked.